Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin Therapy for Endothelial Function in Sickle Cell Disease
NCT00508989Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jul 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niacin in sickle cell disease (SCD), sponsored by National Heart, Lung, and Blood Institute. Started Jul 2007; status: completed.
02
Drugs
niacin
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT00508989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00508989.